# Effects of Erythropoietin for Cognitive Side-effects of ECT

> **NCT03339596** · PHASE2 · COMPLETED · sponsor: **Martin Balslev Jørgensen** · enrollment: 60 (actual)

## Conditions studied

- ECT
- Cognitive Impairment
- Unipolar Depression
- Bipolar Depression

## Interventions

- **DRUG:** Erythropoietin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03339596
- **Lead sponsor:** Martin Balslev Jørgensen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-26
- **Primary completion:** 2023-01-10
- **Final completion:** 2023-02-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339596, "Effects of Erythropoietin for Cognitive Side-effects of ECT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03339596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*